Comparison of TIVA by Closed Loop Anaesthesia Delivery System Versus Target Controlled Infusion Device
NCT04731480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2025-08-14
Summary
Total intravenous anaesthesia (TIVA) is now being adopted as a preferred technique for providing GA because of its various inherent advantages like reduced PONV incidence, improved quality of recovery post GA, anti-inflammatory and anti-oxidant action, anti-neoplastic activity, analgesic action, and absence of greenhouse effect. Over the years propofol-TIVA delivery has become more methodical due to the use of target-controlled infusion (TCI) systems. The current TCI technology has evolved with the introduction of the 'open' TCI concept wherein syringes of any configuration can be attached to the TCI-pumps having pre-programmed propofol PK-PD models. The two most commonly use propofol PK-PD models are the Marsh and Schneider models targeting the propofol blood plasma concentration and effect site concentration in the brain respectively. Automated delivery of propofol using computer-controlled closed loop anaesthesia device delivers propofol based on patient's frontal cortex electrical activity as determined by bispectral index (BIS). Evaluation of anaesthesia delivery by these systems has shown that they deliver propofol and maintain depth of anaesthesia with far more precision as compared to manual administration. A recent advance in propofol delivery has been the development of automated closed loop anaesthesia delivery system. These devices deliver propofol based on patient's frontal cortex electrical activity as determined by bispectral index (BIS).Closed loop anaesthesia delivery system (CLADS) is an indigenously developed continuous automated intravenous infusion system which delivers propofol based on patients' EEG profile (BIS) feedback. Currently there is no data available comparing the efficacy of TCI delivered propofol versus automated propofol delivery systems. The investigators hypothesize that automated propofol delivery by CLADS will provide more consistent anaesthesia depth maintenance as compared to TCI delivered propofol. This randomized controlled study aims to compare the efficiency of CLADS-driven propofol TIVA versus TCI administered in patients undergoing non-cardiac surgery with respect to adequacy of anaesthesia depth maintenance, performance characteristic of propofol delivery system hemodynamic stability, recovery from anaesthesia and postoperative sedation.
Conditions
- Anesthesia
Interventions
- DRUG
-
Propofol
Propofol administration rate will be controlled by a feedback loop facilitated by BIS monitoring using the closed loop anaesthesia delivery system (CLADS). A BIS value of 50 will be used as the target point for induction and maintenance of anaesthesia.
- DRUG
-
Propofol
The target controlled infusion (TCI) pump will be programmed to marsh model with the target plasma site concentration of 3-µg/ml. The plasma concentration will be altered to maintain a target BIS of 50 during induction and maintenance of anesthesia
- DRUG
-
Propofol
The target controlled infusion (TCI) pump will be programmed to Schneider model with the target effect site concentration of 3-µg/ml. The effect-site concentration will be altered to maintain a target BIS of 50 during induction and maintenance of anesthesia
- DRUG
-
Propofol
Manual propofol administration will be done using an intravenous infusion pump to maintain a target BIS of 50 during induction and maintenance of anesthesia.
Sponsors & Collaborators
-
Sir Ganga Ram Hospital
lead OTHER
Principal Investigators
-
Jayashree Sood, MBBS, MD, FFRCA, PGDHHM, FICA · Sir Ganga Ram Hospital, New Delhi, INDIA
-
Goverdhan D Puri, MBBS, MD, PhD · Postgraduate Institute for Medical Education & Research, Chandigarh, India
-
Nitin Sethi, MBBS, DNB · Sir Ganga Ram Hospital, New Delhi, INDIA
-
Amitabh Dutta, MBBS, MD, PGDHR · Sir Ganga Ram Hospital, New Delhi, INDIA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-02
- Primary Completion
- 2025-06-17
- Completion
- 2025-06-17
Countries
- India
Study Locations
More Related Trials
-
Automatic Control of Total Intravenous Anesthesia (ACTIVA)
NCT04432974 ·Status: COMPLETED ·Phase: NA
-
Anesthesia, TIVA, Balanced Anesthesia, NK Cell
NCT05951842 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency
NCT06986109 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Automated Propofol Delivery in Patients Undergoing Thoracic Surgery
NCT03307551 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Propofol-remifentanil Total Intravenous Anesthesia and Desflurane-remifentanil Balanced Anesthesia With Regard to Post-anesthetic Functional Recovery Measured With QoR-40
NCT01760018 ·Status: COMPLETED ·Phase: NA
-
Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming
NCT03476213 ·Status: RECRUITING ·Phase: NA
-
Difference Between Inhalation Anesthesia and Total Intravenous Anesthesia in Free Flap Surgery
NCT03263078 ·Status: COMPLETED ·Phase: NA
-
Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index
NCT02890186 ·Status: UNKNOWN ·Phase: PHASE4
-
Automated Postoperative Sedation After Cardiac Surgery
NCT03517735 ·Status: TERMINATED ·Phase: NA
-
Study to Investigate TIVA With Propofol on Postoperative Pain and Side Effects
NCT03058354 ·Status: WITHDRAWN
-
Total Intravenous Anesthesia With Remifentanil-propofol Admixture
NCT04394897 ·Status: COMPLETED
-
Fully Automated Anesthesia, Analgesia and Fluid Management
NCT02886806 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.
NCT06418893 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Closed Loop Isoflurane Administration With Bispectral Index in Open Heart Surgery
NCT01069562 ·Status: COMPLETED ·Phase: NA
-
Compare the Side Effects and Difference Awake Level of Three TCI Propofol Formula in TVOR Patients
NCT00760253 ·Status: COMPLETED
-
Benefits of Total Intravenous Anesthesia Compared With Inhaled Anesthesia in Cardiovascular Surgery
NCT03233815 ·Status: UNKNOWN
-
Quality of Recovery After Robotic Surgery
NCT03659539 ·Status: COMPLETED ·Phase: NA
-
Propofol Effects on Mitral Valve Annular Velocity
NCT01826149 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Effects of Total Intravenous Anaesthesia With Target-Controlled Infusion (TCI) and Inhalation Anaesthesia on Airway Complications During Extubation and in the Early Postoperative Period in Thyroidectomy Surgery
NCT07325669 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System
NCT02492282 ·Status: COMPLETED ·Phase: PHASE3
-
Closed Loop Propofol Administration in Pediatric Cardiac Surgery
NCT01600287 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients
NCT02686710 ·Status: TERMINATED ·Phase: PHASE4
-
Closed-loop Control of Anesthesia: Controlled Delivery of Remifentanil and Propofol
NCT01771263 ·Status: COMPLETED ·Phase: NA
-
The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients
NCT01720498 ·Status: COMPLETED ·Phase: NA
-
Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)
NCT01618539 ·Status: TERMINATED